Drug Approval | March 22, 2025
SMS Pharmaceuticals completes USFDA inspection at Hyderabad facility
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
The European regulator will conduct a re-inspection of the facility to verify the compliance
Overall investment in the US facility is estimated around US$50 million
Ketoconazole shampoo is an antifungal medication used to treat dandruff
Subscribe To Our Newsletter & Stay Updated
